Physician profile
Paul Citrin
NPI 1043325582
$10,231.36
in general payments reported to CMS, 2019-2025
38 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $1,182 · 2021: $1,318 · 2022: $1,217 · 2023: $1,632 · 2024: $1,759 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,797.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,120.30 | 2019-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Endologix LLC | $1,476.66 | 2019-2022 | |
| Medtronic, INC. | $982.80 | 2022-2025 | Endurant Iis, Hawkone, Heli-Fx Endoanchor System |
| Medtronic Vascular, INC. | $943.65 | 2019-2020 | |
| Cvrx, INC. | $731.87 | 2022-2024 | Barostim Neo System |
| Penumbra, INC. | $447.27 | 2019-2025 | Ruby Coil, Penumbra System |
| Silk Road Medical, INC. | $218.10 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cardiovascular Systems INC. | $196.56 | 2019-2022 | |
| Baxter Healthcare | $196.43 | 2020-2025 | Preveleak, Perclot, Tisseel |
| Cook Medical LLC | $193.12 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $186.15 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $160.09 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $147.61 | 2022-2024 | Bridion |
| Boston Scientific Corporation | $136.43 | 2021-2025 | Varithena Administration Pack |
| Smith+Nephew, INC. | $134.61 | 2019-2024 | Grafix Pl, Pico 14 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $104.23 | 2025 | Artix Mt |
| Shockwave Medical, INC | $92.26 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $79.00 | 2021-2025 | Artegraft Vascular Graft, Restoreflow |
| Kerecis Limited | $67.33 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Inari Medical, INC. | $63.14 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ethicon US, LLC | $54.94 | 2021-2024 | Evarrest, Prolene, Vistaseal |
| Organogenesis INC. | $54.21 | 2022-2025 | Apligraf |
| Kci USA, INC. | $52.66 | 2020-2022 | |
| Surmodics, INC. | $51.36 | 2025 | Pounce Thrombectomy |
| Ets Wound Care LLC | $46.34 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Acera Surgical, INC. | $35.34 | 2024-2025 | Restrata Wound Matrix |
| Bsn Medical INC | $33.39 | 2025 | |
| Abbott Laboratories | $33.24 | 2023 | Diamondback Peripheral |
| Lifenet Health | $28.25 | 2025 | Theragenesis Wound Matrix |
| Inspiremd LTD | $27.55 | 2025 | Cguard Prime Carotid Stent System |
| Chiesi USA, INC. | $24.26 | 2021 | |
| Sanara Medtech INC. | $20.41 | 2025 | Celleraterx |
| Convatec INC. | $18.01 | 2025 | |
| Cashflow Solutions, LLC | $17.63 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Pacira Pharmaceuticals Incorporated | $16.00 | 2021 | |
| Philips North America LLC | $15.30 | 2020 | |
| Integra Lifesciences Corporation | $13.27 | 2022 | |
| Misonix INC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Citrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.